Literature DB >> 7523157

Hereditary deficiency of the seventh component of complement and recurrent meningococcal infection: investigations of an Irish family using a novel haemolytic screening assay for complement activity and C7 M/N allotyping.

L J Egan1, A Orren, J Doherty, R Würzner, C F McCarthy.   

Abstract

Terminal complement component deficiency predisposes to meningococcal infection and is inherited in an autosomal co-dominant manner. An Irish family is described, in which 2 of 3 brothers had recurrent meningococcal infection. A novel screening assay was used to investigate for terminal complement deficiency and the 2 affected brothers were found to be completely deficient in the seventh component of complement (C7). Enzyme-linked immunosorbent assay for C7 revealed lower than normal levels in the remaining brother and parents. C7 M/N protein polymorphism allotyping, used to investigate the segregation of the C7 deficiency genes, showed that the apparently complement sufficient brother was heterozygous C7 deficient and a carrier of one of the deficiency genes. Complement screening should be carried out in any individual suffering recurrent meningococcal infection or infection with an uncommon meningococcal serogroup. Identification of complement deficient patients allows the implementation of strategies to prevent recurrent infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523157      PMCID: PMC2271528          DOI: 10.1017/s0950268800051700

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  20 in total

1.  Prophylaxis against Neisseria meningitidis infections and antibody responses in patients with deficiency of the sixth component of complement.

Authors:  P C Potter; C E Frasch; W J van der Sande; R C Cooper; Y Patel; A Orren
Journal:  J Infect Dis       Date:  1990-05       Impact factor: 5.226

Review 2.  An integrated molecular and immunological approach towards a meningococcal group B vaccine.

Authors:  M R Lifely; C Moreno; J C Lindon
Journal:  Vaccine       Date:  1987-03       Impact factor: 3.641

3.  Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups.

Authors:  C A Fijen; E J Kuijper; A J Hannema; A G Sjöholm; J P van Putten
Journal:  Lancet       Date:  1989-09-09       Impact factor: 79.321

4.  A physical map of the C6 and C7 complement component gene region on chromosome 5p13.

Authors:  M J Hobart; B A Fernie; R G DiScipio; P J Lachmann
Journal:  Hum Mol Genet       Date:  1993-07       Impact factor: 6.150

5.  Bactericidal activity of meningococcal antisera. Blocking by IgA of lytic antibody in human convalescent sera.

Authors:  J M Griffiss
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

6.  Inherited structural variation and linkage relationships of C7.

Authors:  M J Hobart; V Joysey; P J Lachmann
Journal:  J Immunogenet       Date:  1978-06

7.  Neisseria meningitidis and Neisseria gonorrhoeae bacteremia associated with C6, C7, or C8 deficiency.

Authors:  B H Petersen; T J Lee; R Snyderman; G F Brooks
Journal:  Ann Intern Med       Date:  1979-06       Impact factor: 25.391

8.  Killing of Neisseria meningitidis by human neutrophils: implications for normal and complement-deficient individuals.

Authors:  S C Ross; P J Rosenthal; H M Berberich; P Densen
Journal:  J Infect Dis       Date:  1987-06       Impact factor: 5.226

Review 9.  Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency.

Authors:  S C Ross; P Densen
Journal:  Medicine (Baltimore)       Date:  1984-09       Impact factor: 1.889

10.  Hereditary complement deficiency in survivors of meningococcal disease: high prevalence of C7/C8 deficiency in Sephardic (Moroccan) Jews.

Authors:  A Zimran; B Rudensky; M R Kramer; F Tedesco; M Ehrenfeld; R Raz; Z Greif; M Gelber; M Lishner; E Golan
Journal:  Q J Med       Date:  1987-04
View more
  5 in total

1.  An abnormal but functionally active complement component C9 protein found in an Irish family with subtotal C9 deficiency.

Authors:  Ann Orren; Ann M O'Hara; B Paul Morgan; Anthony P Moran; Reinhard Würzner
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

2.  Expression profiling of the cellular processes in uterine leiomyomas: omic approaches and IGF-2 association with leiomyosarcomas.

Authors:  Su Mi Bae; Yong-Wan Kim; Joon Mo Lee; Sung Eun Namkoong; Chong Kook Kim; Woong Shick Ahn
Journal:  Cancer Res Treat       Date:  2004-02-29       Impact factor: 4.679

3.  C7 deficiency in an Irish family: a deletion defect which is predominant in the Irish.

Authors:  A M O'Hara; B A Fernie; A P Moran; Y E Williams; J J Connaughton; A Orren; M J Hobart
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

4.  Targeted cellular process profiling approach for uterine leiomyoma using cDNA microarray, proteomics and gene ontology analysis.

Authors:  Woong Shick Ahn; Ko-Woon Kim; Su Mi Bae; Joo Hee Yoon; Joon Mo Lee; Sung Eun Namkoong; Jin Hong Kim; Chong Kook Kim; Young Joo Lee; Yong-Wan Kim
Journal:  Int J Exp Pathol       Date:  2003-12       Impact factor: 1.925

5.  Two mutations of the C7 gene, c.1424G > A and c.281-1G > T, in two Korean families.

Authors:  Hee Jung Kang; Chang-Seok Ki; Yeon-Sook Kim; Mina Hur; So Ick Jang; Ki Sik Min
Journal:  J Clin Immunol       Date:  2006-03-22       Impact factor: 8.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.